Informações:
Falhas:
ID
34337
Descrição
Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2); ODM derived from: https://clinicaltrials.gov/show/NCT02509871
Link
https://clinicaltrials.gov/show/NCT02509871
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hormonal Therapy NCT02509871
Eligibility Hormonal Therapy NCT02509871
- StudyEvent: Eligibility
Similar models
Eligibility Hormonal Therapy NCT02509871
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
postmenopausal women
boolean
ID.2
Item
patients requiring hormonal treatment
boolean
ID.3
Item
who performance status 0-2
boolean
ID.4
Item
patients initially included in metaca (au882) protocol
boolean
ID.5
Item
affiliation to a social security scheme (or be the beneficiary of such a plan)
boolean
ID.6
Item
patients who signed the informed consent form
boolean
ID.7
Item
patients witg relapse, with metastases or other cancer
boolean
ID.8
Item
concurrent treatment with a drug test, or participation in a clinical trial within < 30 days
boolean
ID.9
Item
patients carrying an electronic medical device (eg pacemaker)
boolean
ID.10
Item
patients who refused to sign the consent form
boolean